HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) SHH

8.30

+0.08(+0.97%)

Updated at August 19 01:43PM

Currency In CNY

Valuation

Market Cap4.35B
Enterprise Value4.12B
P/E Ratio26.67
PEG Ratio-1.64
Price/Sales Ratio0.48
Price/Book Ratio1.65
Enterprise/Revenue0.48
Enterprise/EBITDA16.84

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.02
Operating Margin0.02

Management Effectiveness

Return On Assets0.03
Return On Equity0.06

Income Statement

Revenue10.05B
Revenue/Share17.44
Gross Profit867.38M
EBITDA387.54M
Net Income213.27M
Diluted EPS0.37

Balance Sheet

Total Cash745.67M
Total Cash/Share1.29
Total Debt807.27M
Total Debt/Equity0.28
Current Ratio1.63
Book Value Per Share5.05

Price History

52-Week Change48.57
52-Week High11.28
52-Week Low5.09
Moving Average 50 Days7.97
Moving Average 200 Days7.71

Statistics

Average Volume17.14M
Shares Outstanding579.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.91
Last Split Factor3:2
Last Split DateJune 14, 2011